These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 25629551

  • 1. Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.
    Bao H, Ge Y, Peng A, Gong R.
    Kidney Int; 2015 Jun; 87(6):1176-90. PubMed ID: 25629551
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.
    Xu W, Ge Y, Liu Z, Gong R.
    J Biol Chem; 2015 Jan 16; 290(3):1348-63. PubMed ID: 25468908
    [Abstract] [Full Text] [Related]

  • 6. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD.
    Cell Death Dis; 2014 Mar 27; 5(3):e1142. PubMed ID: 24675460
    [Abstract] [Full Text] [Related]

  • 7. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
    Paeng J, Chang JH, Lee SH, Nam BY, Kang HY, Kim S, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW.
    Apoptosis; 2014 Dec 27; 19(12):1678-90. PubMed ID: 25284613
    [Abstract] [Full Text] [Related]

  • 8. Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.
    Zhou S, Wang P, Qiao Y, Ge Y, Wang Y, Quan S, Yao R, Zhuang S, Wang LJ, Du Y, Liu Z, Gong R.
    J Am Soc Nephrol; 2016 Aug 27; 27(8):2289-308. PubMed ID: 26647425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3β facilitated NFkB activation.
    Wang P, Zhou S, Ge Y, Lu M, Liu Z, Gong R.
    Oncotarget; 2017 Oct 24; 8(51):88332-88344. PubMed ID: 29179438
    [Abstract] [Full Text] [Related]

  • 11. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
    Li C, Ge Y, Peng A, Gong R.
    Oncotarget; 2015 Nov 24; 6(37):39493-506. PubMed ID: 26567873
    [Abstract] [Full Text] [Related]

  • 12. Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression.
    Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S.
    J Biol Chem; 2006 Jun 23; 281(25):16985-16990. PubMed ID: 16601113
    [Abstract] [Full Text] [Related]

  • 13. Inhibiting glycogen synthase kinase 3beta in sepsis.
    Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala E, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C.
    Novartis Found Symp; 2007 Jun 23; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
    [Abstract] [Full Text] [Related]

  • 14. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.
    Biochim Biophys Acta; 2013 Dec 23; 1832(12):2232-43. PubMed ID: 23999007
    [Abstract] [Full Text] [Related]

  • 15. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J, Lei M, Cheng F, Liu Y, Zhou M, Zheng W, Zhou Y, Gong R, Liu Z.
    Cell Death Dis; 2020 Jun 02; 11(6):413. PubMed ID: 32487989
    [Abstract] [Full Text] [Related]

  • 16. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
    Zhang HT, Wang WW, Ren LH, Zhao XX, Wang ZH, Zhuang DL, Bai YN.
    Cell Physiol Biochem; 2016 Jun 02; 40(5):1079-1093. PubMed ID: 27960162
    [Abstract] [Full Text] [Related]

  • 17. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
    Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R.
    Shock; 2008 Sep 02; 30(3):299-307. PubMed ID: 18323734
    [Abstract] [Full Text] [Related]

  • 18. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
    Xia Y, Rao J, Yao A, Zhang F, Li G, Wang X, Lu L.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):117-25. PubMed ID: 23051669
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of lipoic acid through inhibition of GSK-3β in lipopolysaccharide-induced BV-2 microglial cells.
    Koriyama Y, Nakayama Y, Matsugo S, Sugitani K, Ogai K, Takadera T, Kato S.
    Neurosci Res; 2013 Dec 15; 77(1-2):87-96. PubMed ID: 23892131
    [Abstract] [Full Text] [Related]

  • 20. Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling.
    Lu M, Wang P, Ge Y, Dworkin L, Brem A, Liu Z, Gong R.
    Sci Rep; 2018 Aug 15; 8(1):12225. PubMed ID: 30111886
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.